Delivery Order SPE2DR25D3015-SPE2DR26F4ES5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of 1,000 tablets of Lisinopril-HCTZ 10-12.5 mg, a common antihypertensive medication used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,199.34, represents a non-competitive set-aside award and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. The...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a potential value of $1,459.16. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,248.47 delivery order to AmerisourceBergen Drug Corp for Lisinopril tablets, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $15,440 to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 20-12.5 mg Lisinopril-HCTZ. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania over the period of September 21-22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the hypertension medication furthers the Agency's...
- The Defense Logistics Agency Troop Support Medical awarded a $226,120 delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of the generic hypertension medication lisinopril-hydrochlorothiazide. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of DOD healthcare programs. Performance will take place in Conshohocken, Pennsylvania over a three-day period concluding on September 25, 2023....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,233.34 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 1,000 tablets of the pharmaceutical product Lisinopril-Hydrochlorothiazide 10-12.5 mg. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 6, 2023. No set-aside designation was applied to this award made against an...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at two hundred ninety thousand six hundred sixty-four dollars ($290,664) to Amerisourcebergen Drug Corporation for one thousand (1,000) tablets of the pharmaceutical lisinopril hydrochlorothiazide. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania under the terms of the order beginning on September 21, 2023 and concluding on September 22, 2023. As a major provider of...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,836.11, is for the delivery of 1,000 tablets of lisinopril-HCTZ 20-12.5 mg, a medication used to treat high blood pressure. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-three dollars and five cents to Amerisourcebergen Drug Corporation for one thousand tablets of the hypertension medication lisinopril-hydrochlorothiazide. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by June 28, 2023 under the terms of the contract. The parent company, Amerisourcebergen Corporation, will...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4ES5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,297.30 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Lisinopril-Hydrochlorothiazide 20-25 mg, a combination antihypertensive medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on November 14, 2025, with an ultimate completion date of November 17, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies medications and medical commodities across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations worldwide. The company's federal contract portfolio demonstrates extensive capability in delivering both brand-name and generic medications, vaccines, and specialized medical supplies through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 11/14/25 |